Erin Gainer
Angel Investor @ HRA Pharma
Paris, France
Erin Gainer is a seed investor at HRA Pharma in Paris focused on Retail and Fashion. Erin Gainer
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Erin Gainer invests in
Stages Erin Gainer invests in
Countries Erin Gainer invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Retail 1 (33%)
- Fashion 1 (33%)
- E-Commerce 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Convertible Note 1 (33%)
Country
- Lithuania 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The Knotty Ones manufacture wool sweater products. Their products include cotton sweaters, cardigans, crocheted bottoms, kids' cotton sweaters, and accessories. They also provide online shopping and delivery services. The female-founded factories of The Knotty Ones use 100% biodegradable yarns that are not only good for wardrobes but also goodfor the environment. The Knotty Ones helps independent female artisans and female-founded factories in rural Lithuania make knitwear, giving them financial independence and a voice in their homes and communities. | Convertible Note / Sep 11, 2023 | ||
| The Knotty Ones manufacture wool sweater products. Their products include cotton sweaters, cardigans, crocheted bottoms, kids' cotton sweaters, and accessories. They also provide online shopping and delivery services. The female-founded factories of The Knotty Ones use 100% biodegradable yarns that are not only good for wardrobes but also goodfor the environment. The Knotty Ones helps independent female artisans and female-founded factories in rural Lithuania make knitwear, giving them financial independence and a voice in their homes and communities. | $603.4K / Seed / Feb 01, 2021 | ||
| Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brainfunctions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder. | $2.3M / Series A / Feb 26, 2015 |
Co-Investors
About HRA Pharma
HRA Pharma, SA develops and commercializes drugs, devices, and services in the therapeutic areas of reproductive health and endocrine diseases. It offers reproductive health products, which include Norlevo for emergency contraception; Cicatridine for vaginitis and vaginal injury; Delidose, Divina, and Duova for HRT; GyMiso for cervical ripening;and Mona Lisa, a copper contraceptive intrauterine device, as well as endocrinal products that include Lysodren and Lysosafe for adrenal cancer. The company also provides Bemedrex for asthma; Deprenyl for Parkinson's disease; and information and associated services for healthcare providers and other users. In addition, its development pipeline comprises ella/ellaOne, an emergency contraceptive pill; UPA UF, a treatment for uterine fibroids; UPA contraceptive products; Mifedren, a product candidate for a subset of Cushing's syndromes caused by ectopic ACTH(1) secretion; and cell-based therapies for muscle regeneration. The company distributes and markets its products directly in the European Union, including France, Germany, and the United Kingdom, as well as through license agreements in France and internationally. HRA Pharma, SA was founded in 1996 and is based in Paris, France. It has subsidiary locations in Bochum, Germany; London, the United Kingdom; and New York, New York.
HRA Pharma Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Wright
Chief Executive Officer
|
|||
Florian Battung
Chief Corporate Development & Strategy Officer
|
|||
Geoff Allan
CFO
|
|||
Martyn Hilton
Chief Global Commercial Officer
|
|||
Paul Carter
Chief Scientific Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Erin Gainer invest in?
Erin Gainer invests primarily in Retail, Fashion and E-Commerce startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Lithuania. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Erin Gainer?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Erin Gainer last invest?
The most recent investment recorded for Erin Gainer closed in Sep 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
